AI-generated summary
The authors studied high-fluence, low-power laser irradiation (HF-LPLI) in tumor cells and mouse tumor models. They report that treated tumor cells died, activated macrophages, and that tumors shrank with immune cell infiltration, effects they link to a mitochondrial superoxide burst. The authors describe HF-LPLI as potentially effective, but the findings come from cell and animal experiments.
- Who or what was studied
- EMT6 tumor cells and EMT6 tumor-bearing mouse models, with a respiration-deficient EMT6 comparison model; no human participants are described.
- Limits stated in the abstract
- The abstract reports only cell and animal experiments, and does not state sample sizes or the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Mitochondria, Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.